Newsfeeds - Spark Newswire

1 minute read

Biolase Q3 Adj. EBITDA Loss $2.5M, Or $0.03/Share, Sales $9.50M Beat $8.78M Estimate

Today, 3:56 PM

Biolase (NASDAQ:BIOL) reported quarterly sales of $9.50 million which beat the analyst consensus estimate of $8.78 million by 8.20 percent. This is a 45.28 percent increase over sales of $6.54 million the same period

BIOL

6 minute read

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance

By Shanthi Rexaline

Today, 3:56 PM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ACIU

18 minute read

Earnings Scheduled For November 10, 2021

By Benzinga Insights

Today, 3:56 PM

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.

AACG

1 minute read

Earnings

Biolase’s Earnings Outlook

By Benzinga Insights

Today, 3:56 PM

Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement. Analysts estimate that Biolase will likely report an Earnings Per Share (EPS) of $-0.03

BIOL

2 minute read

Earnings

Biolase Earnings Perspective: Return On Invested Capital

By Benzinga Insights

Today, 3:56 PM

According to data from Benzinga Pro, during Q2, Biolase's (NASDAQ:BIOL) reported sales totaled $9.13 million. Despite a 45.84% increase in earnings, the company posted a loss of $3.28 million.

BIOL

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 3:56 PM

Gainers

ANPC

1 minute read

News

BIOLASE Reports Clinical Advisory Partnership With Leading Endodontist, Dr. L. Stephen Buchanan

By Benzinga Newsdesk

Today, 3:56 PM

Today BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan that will help expand laser adoption and increase hands-on training

BIOL

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

Today, 3:56 PM

Gainers

ACRS

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 3:56 PM

ACRX

6 minute read

78 Biggest Movers From Friday

By Lisa Levin

Today, 3:56 PM

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.

ABCL